MODALITY PARTNERSHIP (AWC) — All Prescriptions & Medications — Page 15
Practice Code: B83033 | KEIGHLEY, BD22 8DH
Showing results 701-750 of 1,143
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder 2 kcal/ml m/sk higher volume, higher energy (0913011) | 67 | 1,160 | £4.1K | +574.6% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 67 | 1.5M | £45.8K | +529.5% ▲ |
| 67 | 5,520 | £1.1K | +895.0% ▲ | |
| 67 | 3,270 | £2.8K | +916.2% ▲ | |
| 67 | 3,490 | £7.8K | +339.9% ▲ | |
| Vardenafil | 66 | 372 | £684 | +372.7% ▲ |
| Tube feed 1.2 kcal/ml with fibre (0914021) | 66 | 1.4M | £23.7K | +419.4% ▲ |
| 66 | 4,020 | £1.1K | +534.2% ▲ | |
| Dicycloverine hydrochloride | 65 | 7,760 | £10.4K | +449.1% ▲ |
| Enoxaparin | 65 | 2,199 | £12.6K | +217.1% ▲ |
| Vitamin A | 65 | 3,772 | £365 | +476.3% ▲ |
| Salicylic acid | 65 | 621 | £226 | +414.1% ▲ |
| 65 | 1,591 | £870 | +639.5% ▲ | |
| 65 | 100 | £9.9K | +646.4% ▲ | |
| 65 | 77 | £4.2K | +1,462.7% ▲ | |
| Cefradine | 64 | 1,691 | £999 | +576.0% ▲ |
| 64 | 1,693 | £5.2K | +914.0% ▲ | |
| 64 | 4,385 | £11.5K | +260.7% ▲ | |
| Simeticone | 63 | 1,711 | £274 | +1,049.0% ▲ |
| Testosterone esters | 63 | 94 | £214 | +327.2% ▲ |
| 63 | 220 | £6.7K | +591.6% ▲ | |
| 63 | 100 | £1.7K | +826.1% ▲ | |
| 63 | 11.8K | £2.4K | +527.2% ▲ | |
| Amiloride hydrochloride | 62 | 4,172 | £2.0K | +146.3% ▲ |
| Other barrier preparations | 62 | 2,250 | £239 | +947.9% ▲ |
| 62 | 477 | £757 | +275.7% ▲ | |
| Chlordiazepoxide hydrochloride | 61 | 3,680 | £514 | +321.2% ▲ |
| Dipipanone hydrochloride | 61 | 3,368 | £29.7K | +322.1% ▲ |
| Dienogest | 61 | 2,352 | £1.6K | +742.4% ▲ |
| 61 | 1,249 | £2.9K | +910.5% ▲ | |
| 61 | 1,490 | £19.4K | +483.5% ▲ | |
| 61 | 3,367 | £10.9K | +234.5% ▲ | |
| Tube feed 1.5 kcal/ml (0914021) | 59 | 714.4K | £18.5K | +597.3% ▲ |
| Etodolac | 59 | 1,770 | £870 | +113.1% ▲ |
| Acitretin | 59 | 5,260 | £1.9K | +354.2% ▲ |
| 59 | 372 | £3.1K | +318.8% ▲ | |
| 59 | 3,564 | £883 | +301.0% ▲ | |
| 59 | 1,585 | £1.5K | +242.6% ▲ | |
| Ferric maltol | 58 | 4,116 | £3.5K | +345.8% ▲ |
| RtS 1.5 kcal/ml m/sk higher protein, higher energy (0913061) | 58 | 915.8K | £19.3K | +736.5% ▲ |
| Powder OTC or discontinued soup (0913311) | 58 | 3,295 | £3.2K | +544.8% ▲ |
| Ciprofloxacin | 58 | 295 | £264 | +629.9% ▲ |
| Nepafenac | 58 | 460 | £1.3K | +834.0% ▲ |
| 58 | 59 | £882 | +575.3% ▲ | |
| 58 | 5,190 | £16.5K | +409.2% ▲ | |
| Ready to serve 1.5 kcal/ml smoothie (0913021) | 57 | 148.4K | £3.7K | +811.6% ▲ |
| Tube feed 1 kcal/ml peptide based (0914041) | 57 | 1.1M | £35.9K | +541.4% ▲ |
| 57 | 1,445 | £467 | +317.1% ▲ | |
| Eprosartan | 56 | 2,156 | £954 | +177.4% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 55 | 1.1M | £24.6K | +473.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.